Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark.

Alshannaq, Hamza; Cogswell, Greg; Pollock, Richard F; Ahmed, Waqas; Norman, Greg J; Lynch, Peter M; Roze, Stephane

Alshannaq, Hamza; Cogswell, Greg; Pollock, Richard F; Ahmed, Waqas; Norman, Greg J; Lynch, Peter M; Roze, Stephane.

Afiliação

Alshannaq H; Health Economics and Outcomes Research, Dexcom, San Diego, California, USA.
Cogswell G; Health Economics and Outcomes Research, Dexcom, San Diego, California, USA.
Pollock RF; Health Economics and Outcomes Research, Covalence Research Ltd, Harpenden, UK.
Ahmed W; Health Economics and Outcomes Research, Covalence Research Ltd, Harpenden, UK.
Norman GJ; Health Economics and Outcomes Research, Dexcom, San Diego, California, USA.
Lynch PM; Health Economics and Outcomes Research, Dexcom, San Diego, California, USA.
Roze S; Health Economics and Market Access, Vyoo Agency, Lyon, France.

Diabetes Obes Metab ; 25(9): 2704-2713, 2023 09.

Article em En | MEDLINE | ID: mdl-37334522

Assuntos

Diabetes Mellitus Tipo 1; Humanos; Diabetes Mellitus Tipo 1/tratamento farmacológico; Insulina/uso terapêutico; Glicemia; Automonitorização da Glicemia; Análise Custo-Benefício; Dinamarca/epidemiologia

Palavras-chave

continuous glucose monitoring (CGM); cost-effectiveness; health economics; hypoglycaemia; type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Idioma: En Ano de publicação: 2023 Tipo de documento: Article